Medpace Holdings (MEDP) Asset Utilization Ratio (2016 - 2026)
Medpace Holdings' (MEDP) quarterly Asset Utilization Ratio came in at 1.33 in Q2 2026, up 3.29% on a YoY basis from 1.29 in Q2 2025, and up 1.86% quarter-over-quarter from 1.3 in Q1 2026.
Analysis
Medpace Holdings (MEDP) Asset Utilization Ratio (2016 - 2026) Analysis & Trends
Medpace Holdings (MEDP) has reported Asset Utilization Ratio for 11 consecutive years, with 1.33 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Asset Utilization Ratio rose 3.29% year-over-year to 1.33; the trailing twelve-month figure through Jun 2026 stood at 1.33 (up 3.29% YoY), and the FY2025 full-year result was 1.24, up 10.59% from the prior year.
- Asset Utilization Ratio grew to 1.33 in Q2 2026 per MEDP's latest filing, from 1.3 in the prior quarter.
- Across five years, Asset Utilization Ratio topped out at 1.42 in Q3 2025 and bottomed at 0.81 in Q1 2022.
- Historically, Asset Utilization Ratio has averaged 1.15 across 5 years, with a median of 1.14 in 2023.
- The sharpest annual moves came in 2022 and 2024: Asset Utilization Ratio soared 54.32% in 2022, then fell 16.0% in 2024.
- Over 5 years, Asset Utilization Ratio stood at 1.09 in 2022, then rose by 10.16% to 1.2 in 2023, then fell by 15.99% to 1.01 in 2024, then surged by 34.66% to 1.36 in 2025, then decreased by 2.08% to 1.33 in 2026.
- According to Business Quant data, Asset Utilization Ratio over the past three periods registered 1.33, 1.3, and 1.36 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | 0.57 |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | 1.33 |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | 0.50 |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | 0.52 |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | 0.99 |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | 0.11 |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | 2.01 |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | 0.84 |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | 0.02 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.33 |
| Mar 31, 2026 | 1.30 |
| Dec 31, 2025 | 1.36 |
| Sep 30, 2025 | 1.42 |
| Jun 30, 2025 | 1.29 |
| Mar 31, 2025 | 1.08 |
| Dec 31, 2024 | 1.01 |
| Sep 30, 2024 | 1.03 |
| Jun 30, 2024 | 1.09 |
| Mar 31, 2024 | 1.14 |
| Dec 31, 2023 | 1.20 |
| Sep 30, 2023 | 1.23 |
| Jun 30, 2023 | 1.19 |
| Mar 31, 2023 | 1.14 |
| Dec 31, 2022 | 1.09 |
| Sep 30, 2022 | 1.04 |
| Jun 30, 2022 | 0.97 |
| Mar 31, 2022 | 0.81 |
| Dec 31, 2021 | 0.71 |
| Sep 30, 2021 | 0.72 |